Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bigby

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Archives of Dermatology|March 21, 2007
What are the risks of serious infections and malignancies for patients treated with anti-tumor necrosis factor antibodies?Rosamaria Corona, Michael Bigby
Clinical Evidence|April 20, 2006
WartsMichael Bigby, Sam Gibbs
Journal of the American Academy of Dermatology|May 23, 2006
The frequency of reporting of race/ethnicity in case reportsJane Unaeze, Michael Bigby
Journal of the American Academy of Dermatology|May 23, 2006
Describing patients' "race" in clinical presentations should be abandonedMichael Bigby, Diane Thaler
JAMA|June 30, 2011
Prevention of melanoma with regular sunscreen useJune K Robinson, Michael Bigby
Archives of Dermatology|July 20, 2011
A prospective randomized controlled trial indicates that sunscreen use reduced the risk of developing melanomaMichael Bigby, Caroline C Kim
Archives of Dermatology|August 17, 2011
Atopic dermatitis and attention-deficit/hyperactivity disorder: is there an association?Sarah N Gee, Michael Bigby
Archives of Dermatology|October 20, 2010
Pityriasis versicolor: a systematic review of interventionsStephanie W Hu, Michael Bigby
Journal of the American Academy of Dermatology|May 23, 2006
Proposed policy on identification of race, ethnicity, or skin color in case reports and studies submitted to the Journal of the American Academy of DermatologyMichael Bigby, Jeffrey D Bernhard
JAMA Dermatology|February 22, 2013
The weight of evidence on the association of isotretinoin use and the development of inflammatory bowel diseaseCătălin Mihai Popescu, Michael Bigby
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Archives of Dermatology|March 21, 2007
What are the risks of serious infections and malignancies for patients treated with anti-tumor necrosis factor antibodies?Rosamaria Corona, Michael Bigby
Clinical Evidence|April 20, 2006
WartsMichael Bigby, Sam Gibbs
Journal of the American Academy of Dermatology|May 23, 2006
The frequency of reporting of race/ethnicity in case reportsJane Unaeze, Michael Bigby
Journal of the American Academy of Dermatology|May 23, 2006
Describing patients' "race" in clinical presentations should be abandonedMichael Bigby, Diane Thaler
JAMA|June 30, 2011
Prevention of melanoma with regular sunscreen useJune K Robinson, Michael Bigby
Archives of Dermatology|July 20, 2011
A prospective randomized controlled trial indicates that sunscreen use reduced the risk of developing melanomaMichael Bigby, Caroline C Kim
Archives of Dermatology|August 17, 2011
Atopic dermatitis and attention-deficit/hyperactivity disorder: is there an association?Sarah N Gee, Michael Bigby
Archives of Dermatology|October 20, 2010
Pityriasis versicolor: a systematic review of interventionsStephanie W Hu, Michael Bigby
Journal of the American Academy of Dermatology|May 23, 2006
Proposed policy on identification of race, ethnicity, or skin color in case reports and studies submitted to the Journal of the American Academy of DermatologyMichael Bigby, Jeffrey D Bernhard
JAMA Dermatology|February 22, 2013
The weight of evidence on the association of isotretinoin use and the development of inflammatory bowel diseaseCătălin Mihai Popescu, Michael Bigby
Pageof 5